tiprankstipranks
Trending News
More News >
Linc AB (SE:LINC)
:LINC

Linc AB (LINC) AI Stock Analysis

Compare
0 Followers

Top Page

SE:LINC

Linc AB

(LINC)

Select Model
Select Model
Select Model
Neutral 47 (OpenAI - 5.2)
Rating:47Neutral
Price Target:
kr69.00
▼(-0.58% Downside)
The score is held down primarily by weak financial performance driven by a TTM net loss and especially severe negative cash flow, despite a strong, debt-free balance sheet. Technical indicators are broadly neutral with only mild near-term support, while valuation is challenged by negative earnings and no provided dividend yield.
Positive Factors
Strong Balance Sheet
A debt-free balance sheet with a large equity base reduces financial risk and provides stability, supporting long-term solvency and operational flexibility.
Revenue Growth
Revenue growth indicates potential for increased market penetration and business expansion, which could lead to improved profitability over time.
Industry Focus
Investing in high-growth sectors like medtech and biotechnology positions the company to benefit from long-term industry trends and innovation-driven growth.
Negative Factors
Negative Cash Flow
Persistent negative cash flow strains financial resources and limits the company's ability to reinvest in growth opportunities, impacting long-term sustainability.
Earnings Volatility
Earnings volatility undermines predictability and confidence in financial performance, complicating strategic planning and investment decisions.
Net Loss
Sustained net losses indicate challenges in achieving profitability, which can erode investor confidence and limit access to capital for future growth.

Linc AB (LINC) vs. iShares MSCI Sweden ETF (EWD)

Linc AB Business Overview & Revenue Model

Company DescriptionLinc AB is a private equity and venture capital firm, specializing in early, mid and late venture investments in pharmaceutical, life-science and med-tech companies, respectively. The firm prefers to invest in Nordic companies. It usually invests from SEK 25 million to SEK 250 million, the first investment often being a relatively small one and the follow-up investments comprising the larger part of the investment. Linc AB is based in Stockholm, Sweden.private eequity and venture capital firm, specializing in early, mid and late venture investments in pharmaceutical, life-science and med-tech companies, respectively. The firm prefers to invest in Nordic companies. It usually invests from SEK 25 million to SEK 250 million, the first investment often being a relatively small one and the follow-up investments comprising the larger part of the investment. Linc AB is based in Stockholm, Sweden.
How the Company Makes MoneyLinc AB generates revenue primarily through its investment activities. The company makes money by acquiring equity stakes in promising healthcare companies and later selling these stakes at a profit. The company may also receive dividends from its investments, depending on the profitability of the portfolio companies. Additionally, Linc AB leverages its expertise and network within the healthcare sector to enhance the value of its investments, contributing to potential capital gains. Significant factors contributing to its earnings include the successful identification of high-potential companies and effective portfolio management.

Linc AB Financial Statement Overview

Summary
Linc AB demonstrates a strong equity position and no leverage, providing a stable financial foundation. However, volatility in profitability metrics and inconsistent cash flow generation present challenges. The company needs to focus on stabilizing its profitability and improving cash flow reliability to enhance its financial performance.
Income Statement
Linc AB shows strong growth in revenue over recent years, with a notable increase from 2023 to 2024. However, profitability metrics present a mixed picture. The gross profit and net profit margins are high for 2024, yet there are inconsistencies with previous years, reflecting volatility. EBIT and EBITDA margins are also strong for 2024, but the historical performance shows periods of negative margins, indicating instability in the company's operational efficiency.
Balance Sheet
The balance sheet for Linc AB is strong with a solid equity base and no debt in 2024. The debt-to-equity ratio is zero, highlighting low financial risk. The equity ratio is high, indicating that the company is well-capitalized. However, previous years show some liabilities, though they remain minimal relative to equity, indicating robust financial health over time.
Cash Flow
Cash flow analysis reveals challenges, with volatility in operating cash flow and free cash flow over recent years. While there is positive free cash flow in 2024, prior years show significant negative cash flows, reflecting instability in cash generation. The operating cash flow to net income ratio suggests inconsistency in converting income into cash, posing risks to liquidity management.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue5.50M0.003.65M2.37M4.14M1.31M
Gross Profit-5.34M-7.88M-1.89M-2.66M-2.44M624.00K
EBITDA-79.88M1.30B666.10M-895.91M-36.93M970.30M
Net Income-80.36M1.30B619.46M-723.34M-30.03M833.18M
Balance Sheet
Total Assets4.55B4.84B3.53B2.91B3.76B2.64B
Cash, Cash Equivalents and Short-Term Investments360.34M549.66M519.98M600.55M828.69M21.91M
Total Debt0.000.000.000.000.000.00
Total Liabilities6.04M8.76M2.92M2.85M130.48M144.17M
Stockholders Equity4.54B4.83B3.53B2.91B3.63B2.49B
Cash Flow
Free Cash Flow-1.13B29.68M-80.57M-228.15M-353.84M-14.63M
Operating Cash Flow-1.13B29.68M-80.57M-228.15M-353.84M-14.63M
Investing Cash Flow-40.46M0.000.00-199.75M-339.45M-6.38M
Financing Cash Flow-29.50M0.000.00-5.00M1.16B-7.65M

Linc AB Technical Analysis

Technical Analysis Sentiment
Negative
Last Price69.40
Price Trends
50DMA
69.32
Negative
100DMA
71.99
Negative
200DMA
71.67
Negative
Market Momentum
MACD
-0.52
Positive
RSI
41.20
Neutral
STOCH
9.28
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:LINC, the sentiment is Negative. The current price of 69.4 is above the 20-day moving average (MA) of 68.50, above the 50-day MA of 69.32, and below the 200-day MA of 71.67, indicating a bearish trend. The MACD of -0.52 indicates Positive momentum. The RSI at 41.20 is Neutral, neither overbought nor oversold. The STOCH value of 9.28 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SE:LINC.

Linc AB Peers Comparison

Overall Rating
UnderperformOutperform
Sector (68)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
74
Outperform
kr10.07B7.7612.47%2.18%4.72%-38.28%
68
Neutral
$18.00B11.429.92%3.81%9.73%1.22%
67
Neutral
kr6.23B13.877.83%0.79%-25.75%-27.25%
63
Neutral
kr8.22B41.4115.16%11.30%-14.49%
60
Neutral
kr3.83B78.867.92%0.31%3.71%26.89%
47
Neutral
kr3.84B-47.78-1.58%45733.33%-105.08%
* Financial Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
SE:LINC
Linc AB
66.30
-23.90
-26.50%
SE:CRED.A
Creades AB
74.20
6.94
10.32%
SE:IDUN.B
Idun Industrier AB Class B
333.00
20.85
6.68%
SE:VO2
Vo2 Cap Holding AB
2.35
0.35
17.50%
SE:SVOL.B
Svolder AB Class B
59.65
10.27
20.80%
SE:MCAP
MedCap AB
545.00
-49.00
-8.25%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Dec 30, 2025